Skip to main content
Clinical Trials/ITMCTR2200006054
ITMCTR2200006054
Completed
Phase 1

Study on the clinical efficacy and mechanism of compound Guizhencao granule in the treatment of grade I patients with hypertension based on metabolomics Technology

The First Affiliated Hospital of Henan University of traditional Chinese Medicine0 sitesTBD
Conditionshypertension

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
hypertension
Sponsor
The First Affiliated Hospital of Henan University of traditional Chinese Medicine
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Henan University of traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Meet the grade I diagnostic criteria of hypertension, and the risk stratification is low\-risk or medium\-risk;
  • (2\) Not taking antihypertensive drugs in the past or taking antihypertensive drugs regularly;
  • (3\) Between 35\-55 years old;
  • (4\) Agree to sign informed consent.

Exclusion Criteria

  • (1\) Patients with hypertension grade II or above;
  • (2\) Hypertensive patients with severe target organ damage of liver, kidney, heart and brain;
  • (3\) Allergic constitution, or allergic to a variety of drugs and food;
  • (4\) Women who have pregnancy plans or are pregnant or lactating;
  • (5\) Patients who cannot take care of themselves or oral drugs;
  • (6\) Participate in other clinical researchers within one month;
  • (7\) Suspected or true history of alcohol and drug abuse; Or the study believes that there are patients with inappropriate inclusion factors.

Outcomes

Primary Outcomes

Not specified

Similar Trials